SHANGHAI and CAMBRIDGE, Mass, Nov. 14, 2026 /PRNewswire/ -- Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688), an innovation-driven, global biopharma company, today announced that five of its commercial medicines in China have been included in the country's 2026 National Reimbursement Drug List (NRDL). The update includes two first-time listings,...
HO CHI MINH CITY, Vietnam, Dec. 16, 2025 /PRNewswire/ -- Club Med, the world leader in premium all-inclusive mountain and beach resorts, announced the...
HANGZHOU, China, Dec. 16, 2025 /PRNewswire/ -- Jiuzi Holdings, Inc. (Nasdaq: JZXN) ("Jiuzi" or the "Company") today announced it is in strategic cooperation discussions...
BEIJING, Dec. 16, 2025 /PRNewswire/ -- Autozi Internet Technology (Global) Ltd. (Nasdaq: AZI) (the "Company" or "Autozi") today announced that it has signed a...